Product News

Biological Specialty Company
At-Home Blood Donation Service Launched for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

At-Home Blood Donation Service Launched for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

BSC is collecting blood samples from sick and recovered COVID-19 patients to assist in developing COVID-19 therapies, vaccines, and diagnostic biomarkers

Biological Specialty Company
At-Home Blood Donation Service Launched for COVID-19 Patients Who Want to Help Develop New Drugs and Vaccines

Biological Specialty Company is helping to ensure COVID-19 patients can safely donate blood for researchers working on developing COVID-19 therapies, vaccines, and diagnostic biomarkers.

COLMAR, PA — April 15, 2020 — Biological Specialty Company (BSC) has launched an at-home blood donation service for COVID-19 positive patients. Blood donations are urgently required from patients who are sick with or have recovered from COVID-19 to help develop new therapies, vaccines, and diagnostic biomarkers for the disease. BSC is a critical service supplying more than 30,000 pharma, biotech, diagnostic, and government researchers with human blood products for scientific research.

“It is critically important that the scientific community has access to COVID-19 positive blood samples to advance medical discoveries. We have received hundreds of calls from researchers looking for these samples and most COVID-19 survivors want to do everything they can to help eradicate this disease,” said Lori Ball, chief operating officer at BSC. “We have established a fleet of mobile blood donation units to enable patients to help get these vital COVID-19 positive blood samples into the hands of researchers who need them.” 

Patients who are sick with COVID-19 and quarantined anywhere in the US can now donate blood from the comfort of their home via a BSC mobile donation unit. 

When patients contact BSC, they will be asked some qualifying questions to confirm their eligibility to participate. BSC is seeking blood donors who are over the age of 18 with COVID-19 positive test results confirmed by nasal swab or sera. 

Patients’ personal information will be kept confidential and only health-related data will accompany their blood sample. They will be asked to provide demographic information such as age, race, gender, medications taken, co-morbidities, and smoking status in addition to answering questions about their illness such as symptoms and date of onset.

Donating Blood in Quarantine

After a COVID-19 patient makes a blood donation appointment, a BSC phlebotomist, dressed in full personal protective equipment (PPE), will arrive at their home, explain the informed consent and collection process, and collect the blood sample. Then, they will send the sample to BSC’s lab for processing and distribution.

Donating Blood Post Recovery

People who have recovered from COVID-19 and have had no symptoms for at least 28 days, and have had no close contact exposure to a person with confirmed COVID-19 for 28 days, can elect to either donate via the mobile service or make an appointment to visit a BSC blood donor center.

Potential donors can obtain additional information and schedule an appointment by calling 1-833-GO-4-CURE, visiting www.biospecialty.com or sending an email to donors@biospecialty.com

By supporting the development of a vaccine or therapy for COVID-19, both sick and recovered patients can play an active role in the race to target a cure. 

Biological Specialty Company